AbbVie Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
AbbVie Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q2 2024.
  • AbbVie Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.37B, a 32.3% decline year-over-year.
  • AbbVie Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $5.34B, a 38.5% decline year-over-year.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $4.86B, a 58.9% decline from 2022.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $11.8B, a 2.55% increase from 2021.
  • AbbVie Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $11.5B, a 150% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.34B $1.37B -$654M -32.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.99B $1.37B +$1.13B +473% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $4.86B $822M -$1.65B -66.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $6.51B $1.78B -$2.17B -55% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $8.69B $2.02B +$1.1B +119% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.59B $239M -$4.25B -94.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $11.8B $2.47B -$1.57B -38.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-17
Q3 2022 $13.4B $3.95B +$770M +24.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $12.6B $924M +$158M +20.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $12.5B $4.49B +$937M +26.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $11.5B $4.04B +$4.01B +11133% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-18
Q3 2021 $7.53B $3.18B +$871M +37.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $6.66B $766M +$1.5B Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $5.16B $3.55B +$543M +18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $4.62B $36M -$2.77B -98.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-19
Q3 2020 $7.38B $2.31B +$424M +22.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $6.96B -$738M -$1.48B -200% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $8.44B $3.01B +$554M +22.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $7.88B $2.8B +$4.63B Oct 1, 2019 Dec 31, 2019 10-K 2020-02-21
Q3 2019 $3.26B $1.88B -$863M -31.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $4.12B $741M -$1.24B -62.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $5.36B $2.46B -$327M -11.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $5.69B -$1.83B -$1.88B -3612% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $7.57B $2.75B +$1.12B +68.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 $6.45B $1.98B +$68M +3.55% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $6.38B $2.78B +$1.07B +62.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 $5.31B $52M -$1.34B -96.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $6.65B $1.63B +$33M +2.07% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $6.62B $1.92B +$305M +18.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $6.31B $1.71B +$357M +26.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $5.95B $1.39B -$126M -8.31% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $6.08B $1.6B +$359M +29% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 $5.72B $1.61B +$244M +17.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 $5.48B $1.35B +$332M +32.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 $5.14B $1.52B Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $1.24B Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $1.37B Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $1.02B Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.